Term Gallery logo

Значения термина nonalcoholic steatohepatitis на английском

Значения для термина "nonalcoholic steatohepatitis" отсутствуют.
Использование термина nonalcoholic steatohepatitis на английском
1
Hepatocellular carcinoma is now known to arise in association with nonalcoholic steatohepatitis.
Pubmed
2
Metabolic syndrome characterized by hyperglycemia and hyperinsulinemia contributes to nonalcoholic steatohepatitis-associated liver fibrosis.
Pubmed
3
Background: Obesity is associated with severe co-morbidities such as type 2 diabetes and nonalcoholic steatohepatitis.
Pubmed
4
Hepatocellular carcinoma may arise in the context of nonalcoholic steatohepatitis, often before cirrhosis has developed.
Pubmed
5
Chronic inflammation is the major hallmark of nonalcoholic steatohepatitis (NASH) progression.
Pubmed
6
Liver biopsy remains the gold standard in detection, evaluation, staging, and grading of nonalcoholic steatohepatitis.
Pubmed
7
Cirrhosis etiologies were nonalcoholic steatohepatitis and hepatitis C virus.
Pubmed
8
A 66-year-old man with cryptogenic cirrhosis secondary to nonalcoholic steatohepatitis presented for orthotopic liver transplantation.
Pubmed
9
We identified 9 cases in which malignancy developed against a parenchymal background of histologically-active nonalcoholic steatohepatitis.
Pubmed
10
The sequence of events that lead to inflammation and fibrosing nonalcoholic steatohepatitis (NASH) is incompletely understood.
Pubmed
11
Patients and methods: Twenty nine obese patients with nonalcoholic steatohepatitis were compared with 28 patients with alcoholic liver disease.
Pubmed
12
Hepatocyte apoptosis in nonalcoholic steatohepatitis (NASH) can lead to fibrosis and cirrhosis, which permanently damage the liver.
Pubmed
13
This in turn activates a poorly characterized innate immune response that contributes to nonalcoholic steatohepatitis (NASH) progression.
Pubmed
14
We then compared the prevalence of metabolic syndrome in simple steatosis with that in nonalcoholic steatohepatitis (NASH).
Pubmed
15
Liver-specific inactivation of Blnc1 abrogates high-fat diet-induced hepatic steatosis and insulin resistance and protects mice from diet-induced nonalcoholic steatohepatitis.
Pubmed
16
Conclusions: Loss of PREP lowers the severity of hepatic steatosis and inflammatory responses in a high-fat diet-induced nonalcoholic steatohepatitis model.
Pubmed
Это словосочетание состоит из:
Nonalcoholic steatohepatitis в диалектах
Соединенные Штаты Америки
Частое